Psychedelic therapy gets personal: music or mindfulness for depression?

NCT ID NCT07373535

Not yet recruiting Symptom relief Sponsor: Kyle Greenway Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether tailoring psilocybin-assisted therapy to a person's preferences (music or mindfulness) is practical and helpful for treatment-resistant depression. Sixteen adults will receive two doses of psilocybin, each paired with a different therapy style, to see if matching the approach to their preference improves mood and well-being. The goal is to learn how to make this promising treatment more effective and personalized.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depressive Disorder, Treatment-Resistant major depressive disorder Patient Preference

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER

Contacts and locations

Show contact details

Locations

Jewish General Hospital

Montreal, Quebec, H3T 1E2, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••
Jewish General Hospital

Montreal, Quebec, Canada